Skip to main content
. 2019 Jul 17;11(7):995. doi: 10.3390/cancers11070995

Figure 1.

Figure 1

Androgen receptor (AR) expression in the seven cohorts of our multi-institutional study. (A) Representative micrographs showing AR expression in triple-negative breast cancer (TNBC) and their adjacent normal tissues, AR (brown) and nuclei (blue). Insets: 20× magnification. (B) Expression of AR in the different study cohorts. (C) Expression of AR among African Americans (AAs) and European Americans (EAs) in the US cohort. The p-value shows the significant difference in AR expression among AAs and EAs.